Explore chapters and articles related to this topic
Systemic Diseases and the Skin
Published in Ayşe Serap Karadağ, Lawrence Charles Parish, Jordan V. Wang, Roxburgh's Common Skin Diseases, 2022
Jana Kazandjieva, Razvigor Darlenski, Nikolai Tsankov
Definition: Bowel-associated dermatosis-arthritis syndrome (BADAS) is a noninfectious neutrophilic dermatosis that occurs in multiple conditions, including intestinal surgery and inflammatory bowel diseases. The syndrome was first described in patients with jejunoileal bypass surgery for obesity.
Obesity
Published in Vincenzo Berghella, Maternal-Fetal Evidence Based Guidelines, 2022
Bariatric surgery procedures are generally categorized into three groups: 1) restrictive procedures 2) malabsorptive procedures and 3) restrictive and malabsorptive procedures. Restrictive procedures (e.g. laparoscopic adjustable gastric banging [LAGB], sleeve gastrectomy) reduce gastric capacity, which consequently restricts energy intake [115–117]. Malabsorptive procedures (e.g. biliopancreatic diversion, jejunoileal bypass) cause weight loss by restricting absorption of nutrients; however, these procedures are rarely performed, as they have been associated with long-term complications like hepatic failure [118, 119]. Lastly, malabsorptive and restrictive procedures (e.g. Roux-en-Y gastric bypass) reduce stomach capacity causing malabsorption and a restriction of food intake. Intragastric balloon appears to have little benefit in weight loss therapy over diet, behavior modification, and motivation [120]. Adjustable gastric band management during pregnancy is not well defined, but almost 20% may need adjustment or removal of band for nausea and vomiting [121].
Treatment of Latent Tuberculosis Infection Including Risk Factors for the Development of Tuberculosis
Published in Lloyd N. Friedman, Martin Dedicoat, Peter D. O. Davies, Clinical Tuberculosis, 2020
Surgery for morbid obesity, especially jejunoileal bypass surgery, has been shown to be very effective, leading to significant weight loss. It has also been associated with an increased risk of TB. The increased risk has been reported to be between 27 and 63 that of the general population.140,141 Laparoscopic weight loss techniques such as gastric banding do not seem to confer the same risk of TB compared to older surgical techniques, although there are case reports of TB after these procedures.142 This reduced risk may be because laparoscopic techniques cause less profound weight loss.
Causes of AA amyloidosis: a systematic review
Published in Amyloid, 2020
Anne Floor Brunger, Hans L. A. Nienhuis, Johan Bijzet, Bouke P. C. Hazenberg
Most (43 out of 49 [1], 35 out of 41 [28] and 44 out of 58 [29]) of the associated diseases listed earlier in the literature appear to be strongly or weakly associated (Tables 1 and 2). Fifteen diseases have now been assessed differently. Polyarteritis nodosa (categorized as vasculitis, not further specified), sickle cell anaemia, gastrointestinal stromal tumour (GIST) and human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) are presented as unclearly associated in Table 3. HIV/AIDS as direct cause because of viral infection (HIV) was deemed unclearly associated. HIV/AIDS as indirect cause because of immunodeficiency (AIDS) was also unclearly associated because it was generally found in combination with skin popping, intravenous drug abuse, or other earlier or concurrent infections instead of a subsequent infection. Jejuno-ileal bypass was deemed unlikely in Table 4 because morbid adiposity is the logical pre-existing underlying condition. Schnitzler’s syndrome, primary ciliary dyskinesia (PCD), antineutrophil cytoplasmic antibody-associated (ANCA)-vasculitis and hairy cell leukaemia were also deemed unlikely since there was only one well-described case for these diseases. For both hyper immunoglobulin M (IgM) syndrome and SAPHO (synovitis, acne, pustulosis, hyperostosis and osteitis) syndrome three case reports were found, in none of which amyloid was characterized. Subacute bacterial endocarditis, inflammatory abdominal aortic aneurysm and myxoma were only once reported in the last decennia, whereas references concerning carcinoid tumour were not found.
Resolution of late-onset heart and liver failures after reversion of jejuno-ileal bypass: a case report
Published in Scandinavian Journal of Gastroenterology, 2018
Giovanna Pelà, Fabrizio De Rosa, Pierluigi Demola, Antonio Crocamo, Gabriele Missale, Stefano Cecchini, Federico Marchesi, Francesco Visioli, Enrico Maria Silini, Luigi Roncoroni
Bariatric surgery is the most potent treatment of morbid obesity and results in effective and sustainable weight losses. However, side effects such as nutritional and metabolic deficiency due to malabsorption may occur post-operatively [1,2]. The jejuno-ileal bypass (JIB) was a popular mode of bariatric surgery in the sixties and seventies. The procedure was performed by creating a short bowel syndrome with an end-to-side JIB [1–4]. This kind of bariatric surgery was gradually dismissed in the early eighties because of important complications, e.g. diarrhea, electrolyte disturbance, arthralgia, osteomalacia and oxalate kidney stones [2]. One of the most feared and serious sequela of JIB is hepatic dysfunction, which generally occurs in the first post-operative years and that can be fatal or lead to the re-establishment of bowel continuity or liver transplantation [5–7]. JIB-induced metabolic cardiomyopathy has never been described [8].
Technical aspects and standardization of the totally robotic Roux-en-Y gastric bypass. Results of a single surgeon experience with a 5-year follow-up
Published in Acta Chirurgica Belgica, 2022
Emmelie Reynvoet, Veerle Van Vlodrop, Kurt Hendrick, Dries Vandeweyer, Carlos Vaz
Various bariatric procedures have been performed in the past, such as jejunoileal bypass, Roux-en-Y gastric bypass (RYGB), vertical banded gastroplasty, biliopancreatic diversion, duodenal switch, adjustable gastric banding and sleeve gastrectomy, but soon, the Roux-en-Y gastric bypass turned out to be the preferred operation regarding weight loss, metabolic benefits, and low complication rate. With the publication of the first laparoscopic RYGB by Wittgrove et al. in 1994, it gained general acceptance as the principal bariatric procedure [2].